Clinical Trial Update: Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 [Phase 3]

View source ↗

Summary

Long-term safety and efficacy results for sirukumab in rheumatoid arthritis patients who completed prior phase 3 studies CNTO136ARA3002 or CNTO136ARA3003 have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Sirukumab (sirukumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED | Results posted: 2019-05-06